Transplantation

Altered HBV Variants Influence Liver Transplant Outcome

Published in Virus Weekly, March 30th, 1998

Antigenically altered hepatitis B virus variants s144 and s145 can be selected by hepatitis B hyperimmune globulin (HBIG) and can influence clinical outcome following liver transplantation.

Orthotopic liver transplantation (OLT) is often the only therapeutic option for patients with acute or chronic liver failure caused by viral hepatitis. However, infection of the liver graft by persisting virus is frequent in these patients who receive immunosuppressive medication to prevent graft rejection. Immunosuppressive drugs impair the T-cell response that is necessary to eliminate viral antigens, and corticosteroids can directly stimulate hepatitis B virus (HBV)...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Virus Weekly

Source: Virus Weekly (1998-03-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry